Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras

被引:54
|
作者
Shi, Ming [1 ]
Zheng, Yang [1 ]
Garcia, Avalon [1 ]
Xu, Lizhong [1 ]
Foster, David A. [1 ]
机构
[1] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA
关键词
phospholipase D; ras; ral; survival signals; apoptosis;
D O I
10.1016/j.canlet.2007.09.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Phospholipase D (PLD) is elevated in rodent fibroblasts expressing activated H-Ras mutants. We therefore examined the PLD activity in human cancer cells with activating Ras mutations. T24 bladder carcinoma cells express an activated H-Ras gene and Calu-1 lung carcinoma cells express an activated K-Ras gene. We report here that both of these cancer cell lines express highly elevated levels of PLD activity and that the PLD activity is dependent upon Ras. We also show that the PLD activity is dependent upon the Ras effector molecules Ra1A and phosphatidylinositol-3-kinasc (PI3K). PLD activity has been shown to provide a survival signal in breast cancer cell lines that suppressed stress-induced apoptosis. Suppression of PLD activity in the T24 and Calu-1 cells resulted in apoptotic cell death in the absence of serum, indicating that the elevated PLD activity provided a survival signal in these cancer cell lines. Suppression of Ras, Ra1A, or PI3K also led to apoptosis in the absence of serum. These data indicate that a critical component of Ras signaling in human cancer cells is the activation of PLD and that targeting PLD survival signals in cancer cells could be an effective strategy to induce apoptosis in human cancers with activating Ras mutations. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:268 / 275
页数:8
相关论文
共 50 条
  • [21] Conformational and structural dynamics of K-ras and H-ras proteins: Specificity at the catalytic domain?
    Rambahal, Nandini
    Hocker, Harrison H.
    Gorfe, Alemayehu A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [22] SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and Signaling
    Siljamaki, Elina
    Abankwa, Daniel
    MOLECULAR AND CELLULAR BIOLOGY, 2016, 36 (20) : 2612 - 2625
  • [23] ANALYSIS OF H-RAS, K-RAS AND N-RAS GENES FOR EXPRESSION, MUTATION AND AMPLIFICATION IN LARYNGEAL TUMORS
    KIARIS, H
    SPANDIDOS, DA
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (01) : 75 - 80
  • [24] Analysis of K-ras, N-ras, H-ras, and p53 in lung neuroendocrine neoplasms
    Couce, ME
    Bautista, D
    Costa, J
    Carter, D
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1999, 8 (02) : 71 - 79
  • [25] Activated K-Ras, but Not H-Ras or N-Ras, Regulates Brain Neural Stem Cell Proliferation in a Raf/Rb-Dependent Manner
    Bender, R. Hugh F.
    Haigis, Kevin M.
    Gutmann, David H.
    STEM CELLS, 2015, 33 (06) : 1998 - 2010
  • [26] The K-Ras, N-Ras, and H-Ras Isoforms: Unique Conformational Preferences and Implications for Targeting Oncogenic Mutants
    Parker, Jillian A.
    Mattos, Carla
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (08):
  • [27] Distinct functions of H-Ras and K-Ras in proliferation and survival of primary hepatocytes due to selective activation of ERK and PI3K
    Rosseland, Carola M.
    Wierod, Lene
    Flinder, Liv I.
    Oksvold, Morten P.
    Skarpen, Ellen
    Huitfeldt, Henrik S.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2008, 215 (03) : 818 - 826
  • [28] MUTATIONS OF K-RAS ONCOGENE AND ABSENCE OF H-RAS MUTATIONS IN SQUAMOUS-CELL CARCINOMAS OF THE LUNG
    VACHTENHEIM, J
    HORAKOVA, I
    NOVOTNA, H
    OPALKA, P
    ROUBKOVA, H
    CLINICAL CANCER RESEARCH, 1995, 1 (03) : 359 - 365
  • [29] H-Ras but not K-Ras is responsible for reactive oxygen species generation by scleroderma skin fibroblasts.
    Gabrielli, A
    Baroni, SS
    Sambo, P
    Paroncini, P
    Luchetti, M
    Avvedimento, E
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S193 - S193
  • [30] IMMUNOHISTOCHEMICAL DETECTION OF THE H-RAS, K-RAS, AND N-RAS ONCOGENES IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    MCDONALD, JS
    JONES, H
    PAVELIC, ZP
    PAVELIC, LJ
    STAMBROOK, PJ
    GLUCKMAN, JL
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1994, 23 (08) : 342 - 346